ArticleMedicines (Basel, Switzerland)2020
Correction: Oral Intake of Royal Jelly Has Protective Effects against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial.
Kyohei Araki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.